Pharmacokinetics and bioavailability of a controlled release amoxicillin formulation

Area of Science:

• Pharmacology
• Drug Delivery Systems
• Clinical Pharmacology

Background:

• Controlled-release drug formulations aim to optimize therapeutic outcomes.
• Understanding amoxicillin pharmacokinetics is crucial for effective antibiotic therapy.
• In vitro dissolution testing is a standard method for predicting drug release.

Purpose of the Study:

• To evaluate the pharmacokinetics and bioavailability of a novel in vitro controlled-release amoxicillin formulation.
• To compare this formulation against intravenous injection and a conventional amoxicillin tablet.
• To investigate the correlation between in vitro drug dissolution and in vivo pharmacokinetic performance.

Main Methods:

• A crossover study involving nine healthy volunteers.
• Administration of three amoxicillin formulations: intravenous, conventional tablet, and controlled-release.
• Plasma amoxicillin concentrations measured using a microbiological assay.
• Non-compartmental analysis to estimate absolute bioavailability of solid dosage forms.

Main Results:

• The controlled-release formulation exhibited distinct pharmacokinetic behavior compared to other forms.
• Absolute bioavailability of the conventional tablet and controlled-release formulation was determined.
• A significant finding was the lack of correlation between in vitro dissolution rates and in vivo pharmacokinetic parameters.

Conclusions:

• The in vitro dissolution rate of amoxicillin does not reliably predict its in vivo pharmacokinetic behavior.
• Further research is needed to optimize controlled-release amoxicillin formulations based on in vivo data.
• Clinical efficacy of controlled-release amoxicillin should be assessed through direct pharmacokinetic and clinical studies rather than solely relying on in vitro dissolution.